Navigation Links
IPC The Hospitalist Company Presents IPC Hospitalist of the Year Award to Tim Osonma, M.D.
Date:3/12/2009

San Antonio Physician First to Receive New Accolade

NORTH HOLLYWOOD, Calif., March 12 /PRNewswire-FirstCall/ -- IPC The Hospitalist Company, Inc. (Nasdaq: IPCM), a leading national physician group practice company, announced today that Timothy Osonma, M.D. has been presented with the IPC Hospitalist of the Year Award for 2008. The award was given to Dr. Osonma at a dinner on February 25th in San Antonio, TX, where he practices. Selected by the senior management team, the award includes an honorarium to Dr. Osonma. Additionally, IPC will make a $2,500 donation to the Methodist Healthcare Ministries in San Antonio, a charity designated by Dr. Osonma.

Adam Singer, M.D., Chairman and CEO, said, "Tim was selected from a field of over a thousand providers that are employed by or affiliated with IPC. It is clear to all at IPC that Tim embodies the highest standards of excellence in hospitalist medicine, which, in a word, is leadership. The practice of hospitalist medicine continues to make great strides as exemplified by Dr. Osonma's ability to lead practice groups and provide high quality inpatient care to hospital patients. At IPC, we are striving to improve the delivery of hospitalist medicine, and are fortunate to have Tim help lead us in that direction."

John Geanes, IPC's Executive Director for the San Antonio region, commented, "Dr. Osonma's practice group is as well managed and effective a hospitalist practice as I have ever seen. Tim is consistently admired by his fellow hospitalists, the hospital's medical and executive staff, and most importantly, his patients. As an organization, we are fortunate to have many outstanding hospitalists at IPC, but none could be more deserving of this award as Tim."

Born in Nigeria, Dr. Osonma completed his postgraduate training at Columbia University's College of Physicians and Surgeons at Harlem Hospital in 1995. Dr. Osonma has been an IPC hospitalist since 2003 at Methodist Hospital, where he sits on several clinical and executive committees. In accepting the award, Dr. Osonma commented, "I am honored to be selected among such a fine and dedicated group of hospitalists as those that work with IPC. I am fortunate to be supported in my vision of how hospitalist medicine should be practiced."

About IPC The Hospitalist Company, Inc.

IPC The Hospitalist Company, Inc. (Nasdaq: IPCM) is a leading national physician group practice company focused on the delivery of hospitalist medicine services. IPC's physicians and affiliated providers manage the care of hospitalized patients in coordination with primary care physicians and specialists. The Company provides its hospitalists with the comprehensive training, information technology, and management support systems necessary to improve the quality and reduce the cost of inpatient care in the facilities it serves. For more information, visit the IPC website at www.hospitalist.com.

    Media Contact:
    Scott Public Relations
    Elaine Murphy
    818.610.0270
    elaine@scottpublicrelations.com

    Investor Contact:
    The Ruth Group
    Stephanie Carrington/Amy Glynn
    646-536-7017/7023
    scarrington@theruthgroup.com
    aglynn@theruthgroup.com


'/>"/>
SOURCE IPC The Hospitalist Company, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Benefits of hospitalist care confirmed in new study
2. Hospitalist Physicians Help Shorten Patient Stays
3. IPC The Hospitalist Company, Inc. Prices Initial Public Offering
4. IPC The Hospitalist Company, Inc. to Present at the 2008 UBS Global Healthcare Services Conference
5. IPC The Hospitalist Company, Inc. Announces Closing of IPO and Exercise of Underwriters Over-Allotment Option
6. IPC The Hospitalist Company, Inc. to Report Fourth Quarter and Year-End 2007 Financial Results
7. IPC The Hospitalist Company Announces Board of Director Member Changes
8. IPC The Hospitalist Company Reports Fourth Quarter and Full Year 2007 Results
9. IPC The Hospitalist Company Sets 2008 Annual Meeting Date
10. IPC The Hospitalist Company Added to Russell 2000 Index
11. IPC The Hospitalist Company, Inc. to Report First Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2017)... Texas (PRWEB) , ... August 19, 2017 , ... ... with contemporary illustrations of breastfeeding mothers. These illustrations show the diversity ... available in prints in a wide range of sizes. These illustrations are also ...
(Date:8/19/2017)... ... ... “Congratulations! It's A Boy! God’s Gift: A Story of Love”: a children’s book ... A Boy! God’s Gift: A Story of Love” is the creation of published authors, ... by Christian Faith Publishing, Dale Anthony and Rachael Anthony’s new book is a perfect ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... (“Quick”), a highly specialized asset-light logistics provider of complex transport solutions for ... agreement to purchase Unitrans International Corporation, a division of Roadrunner Transportation Systems, ...
(Date:8/18/2017)... ... August 18, 2017 , ... As an industry leader, ... webinar, they will present the line of epMotion automated liquid handling system. This ... can automate everyday pipetting tasks. , Ideal for scientists and lab technicians with ...
(Date:8/18/2017)... TX (PRWEB) , ... August 18, 2017 , ... ... assistance and financial planning services to communities in east Texas, is launching a ... Brain Tumor Foundation. , Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... 2017  Axium Pharmaceuticals Inc., the creator of the drug Truveta ... beginning stages of an IPO. The United States ... average cost of a prescription epilepsy drug being $450.00-$1200.00 for a one ... AXIUM PHARMACEUTICALS, INC ... Another staggering figure is the fact that Americans spent $42 billion ...
(Date:8/14/2017)... and PETACH TIKVAH, Israel ... (NASDAQ: BCLI), a leading developer of adult stem cell ... second quarter ending June 30, 2017. ... of preparing for our pivotal Phase 3 trial to ... Lebovits , President and Chief Executive Officer of BrainStorm. ...
(Date:8/8/2017)... 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical ... financial results for the second quarter ended June 30, ... quarter 2017 and to date: ... for the Company,s lead project, BL-8040: ... BL-8040 as novel stem cell mobilization treatment for autologous ...
Breaking Medicine Technology: